A 46-year-old female patient with non-alcoholic steatohepatitis ( NASH ) was administered nateglinide, an insulin secretagogue, for 7 months, and then polyenephosphatidylcholine, an antioxidant medication, in accordance with the twostep hypothesis of NASH, with insulin resistance as the initial pathogenesis and oxidative stress as the second. HOMA-R, an index of insulin resistance, improved, and hepatic marker levels improved markedly by four weeks after initiation of polyenephosphatidylcholine. The beneficial effects of treatment continued over the 24 months of the study. A liver biopsy evaluated using Brunt's criteria showed improvement from stage 2 to stage 0 after 9 months. These findings suggest the therapeutic efficacy of step by step treatment of NASH in accordance with the two-stage hypothesis.
Introduction
Non-alcoholic steatohepatitis (NASH), a fibrotic and necro-inflammatory hepatic disorder associated with remarkable fatty infiltration of hepatocytes, was first reported by Ludwig et al. in 1980 [1] . Although it is progressive, ha a poor prognosis , and sometimes progresses to cryptogenic cirrhosis , NASH is usually asymptomatic and also has non-specific symptoms [2] . Consequently , early pathologic diagnosis and treatment are necessary. Although the pathogenic mechanism of NASH remains unclear, a "two-hit" mechanism is considered most likely [3] . An increased supply of free fatty acids to the liver and compensatory hyperinsulinaemia play crucial roles in the pathogenesis of insulin resistance as the first step, resulting in initiation of hepatic steatosis .
Excessive free fatty acids in the liver then promote production of reactive oxygen species in hepatic PPC has been shown to attenuate alcohol-induced oxidative stress in rats [4] and in baboons [5] . PPC decreases alcohol-induced hepatic oxidative stress and restores hepatic S-adenosylmethionine [6] . PPC also attenuates alcohol-induced apoptosis of hepatocytes and protects against liver cell injury, possibly as a result of its antioxidative effect, which is due to down-regulation of ethanolmediated CYP2E1 induction [7] .
We report on a case of NASH with rapid and pronounced improvement of elevated hepatic marker levels and the pathological findings after the oral administration of PPC beginning 7 months after pre-administration of an insulin secretagogueagent, nateglinide, which has been shown to improve insulin resistance [8] .
Case report
During a routine checkup, a female patient 46 years of age (height 158.6 cm, body weight 69.9
kg, body mass index (BMI) 27.5 kg/m 2 , and blood pressure 126/78 mmHg) was found to have [9, 10] and a quantitative insulin sensitivity check index (QUICKI, normal range : more than 0.357) [11] suggested high insulin resistance. After obtaining informed consent, in April 2003, we began administration of 270 mg/ day of nateglinide, which has shown to improve postprandial hyperglycemia and insulin resistance [12] . Despite a lack of habitual alcohol consumption and viral infections, her hepatic function test results were abnormally elevated (Table 1) Serum ferritin also improved after beginning administration of PPC, and remained within lownormal range for the 24 months of the study (Table 2 ). There were no remarkable changes in other laboratory findings, including measures of cholesterols and uric acid ( Table 2 ). An abdominal ultrasound examination 6 months after initiation of treatment with PPC revealed improvement in the deep echo attenuation using hepato-renal echo contrast (Figure 2 (B) ), which also indicated improvement of fatty change in the liver. A second liver biopsy was performed 9 months after the start of PPC administration. A comparison of the pathological features using Brunt's criteria [13] is shown in Table 3 . Comparison of the pathologic findings for the liver biopsies revealed improvement, with remarkable reduction of hepatocellular steatosis and ballooning, rare (Figure 3 (B) ). Despite the fact that no other methods of treatment including diet or exercise therapy were used, these improvements were obtained. In addition, there was a gradual improvement in BMI and insulin resistance without any change in waist circumference ( Table   2 ).
Discussion
This study documents a case of remarkable improvement of NASH using a two-step treatment with nateglinide followed by PPC. This is a reasonable step by step treatment of NASH according to the "two-hit" hypothesis. Although the two stage hypothesis for NASH has yet to be proven conclusively correct, the findings described in our case report are consistent with it.
According to the theory that the pathogenesis of NASH is initially insulin resistance, prevention of this first step is critical when initiating treatment.
A recent study showed that troglitazone, a thiazolidinedione, and peroxisome proliferatoractivated receptor gamma (PPARgamma), a ligand known to improve insulin resistance , can normalize liver enzyme levels in patients with NASH [14] . Nateglinide has also been shown to improve excessive postprandial elevation of glucose by augmentation of early insulin secretion after meals, as well as to improve insulin levels and the HOMA-R index, thus suggesting a direct effect of nateglinide in improving insulin resistance [15] . However, in our patients the beneficial effect of nateglinide alone was limited to improvement of hepatic dysfunction. [16] .
Additionally, we had the impression that the Abbreviations : M : month, PPC : polyemylphosphatidylcholine oxidative stress [17] . Insulin resistance is also associated with hepatic iron overload [18] . Although the exact mechanism of PPC on liver iron metabolism is unclear, the reduction of serum ferritin in our patient may also indicate prevention of both insulin resistance and oxidative stress by PPC and nateglinide, with attenuation of injury to liver tissue.
In conclusion, we have presented findings suggesting the usefulness of administering PPC together with nateglinide in treating NASH. These findings suggest the importance of further clinical evaluation of a combined treatment of nateglinide and PPC according to the two stage hypothesis for NASH.
